Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end […]
WALTHAM, Mass. — Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative. The Somatic Reference Samples (SRS) Initiative is a public-private partnership convened and […]
License enables Dyadic Applied BioSolutions to expand genetic engineering capabilities Dublin, Ireland, and Jupiter FL, USA: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions (‘Dyadic’), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced they have signed a non-exclusive agreement granting access to ERS’ foundational […]
Following global commercial launch in September, Illumina Protein Prep’s “out of the box” solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exceptional […]
Oxford, UK – Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) – the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of expertise in hybrid capture technology, the panel detects ultra-low frequency variants in key MRD-associated biomarkers in acute myeloid leukaemia (AML). This means users […]
QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight workflows for comprehensive genomic profiling (CGP) based on Element Biosciences Trinity™ technology Partnership with Myriad Genetics Inc. to highlight development of a […]
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. — Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company’s next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. […]
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland — SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing […]
NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α NanoTemper’s two strategic milestones – NSM technology acquisition and the launch of Dianthus™ α application – expand its capabilities across the life sciences value chain and enhance support for the discovery of next-generation therapeutics. The Envue Technologies acquisition brings Nanofluidic Scattering […]
CAMBRIDGE, England — Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a […]
Pay Invoice
Latest Blogs
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
